Robert T. Foster - Concepedia

Author

Robert T. Foster

Also Known As

Foster, Robert Thomas., R Foster, R T Foster, R. Foster, R. T. Foster, R.T. Foster, R.T. Foster II, ROBERT T. FOSTER, Robert Foster, Robert T Foster

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Alberta Edison Pharmaceuticals (United States)Scripps Research Institute Elanco (United States)Université de Montréal

About

Robert T. Foster is an author at University of Alberta specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	1.4K
2	Health Sciences	5	5	177
3	Anesthesia	2	2	35
4	Engineering	1	1	20
5	Natural Sciences	1	1	13

Robert T. Foster

Publications

Citations

H-Index

Page 1

	Year	Citations
High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine Robert T. Foster, Fakhreddin Jamali Journal of Chromatography B Biomedical Sciences and Applications Ketoprofen EnantiomersMedicineHuman PlasmaAnalytical ChemistryLiquid Chromatography	1987	114
Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration. Robert T. Foster, Fakhreddin Jamali Drug Metabolism and Disposition	1988	110
Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses Robert T. Foster, F. Jamali, Anthony S. Russell, Journal of Pharmaceutical Sciences Molecular PharmacologyKetoprofen EnantiomersHealthy SubjectsPharmacological StudyMultiple Doses	1988	108
Aging of hops and their contribution to beer flavor Kai C. Lam, Robert T. Foster, Max L. Deinzer Journal of Agricultural and Food Chemistry NutritionAgingAltmetric Attention ScoreBibliometricsBeer Flavor	1986	84
Pharmacokinetics of Ketoprofen Enantiomers in Young and Elderly Arthritic Patients following Single and Multiple Doses Robert T. Foster, Fakhreddin Jamali, Anthony S. Russell, Journal of Pharmaceutical Sciences RheumatologyKetoprofen EnantiomersPharmacological StudyMultiple DosesMedicine	1988	73
Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test John S. Grundy, Keith E. Anderson, James A. Rogers, Journal of Controlled Release Pharmaceutical ScienceGastrointestinal PharmacologyMedicineDissolution TestingVitro Dissolution Test	1997	69
ISATX247: a novel calcineurin inhibitor Launa J. Aspeslet, Derrick G. Freitag, D.J. Trepanier, Transplantation Proceedings Molecular PharmacologyMedicineMechanism Of ActionPharmacotherapyNovel Calcineurin Inhibitor	2001	63
A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis Robert Bissonnette, Kim Papp, Yves Poulin, Journal of the American Academy of Dermatology Placebo-controlled Phase 2Clinical TrialsClinical DermatologyChronic Plaque PsoriasisDermatology	2006	56
Ketoprofen Pharmacokinetics in Humans: Evidence of Enantiomeric Inversion and Lack of Interaction Fakhreddin Jamali, Anthony S. Russell, Robert T. Foster, Journal of Pharmaceutical Sciences Pharmacological StudyMedicineKetoprofen PharmacokineticsEnantiomeric InversionPharmacotherapy	1990	54
A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models Joseph Kuo, Michael Bobardt, Udayan Chatterji, Journal of Pharmacology and Experimental Therapeutics	2019	51

Page 1